Myeloid-Derived Suppressor Cells: Ductile Targets in Disease

Discussion MDSCs violently emerge in pathological conditions in an attempt to limit potentially harmful immune and inflammatory responses. Mechanisms supporting their expansion and survival are deeply investigated in cancer, in the perspective to reactivate specific antitumor responses and prevent their contribution to disease evolution. These findings will likely contribute to improve the targeting of MDSCs in anticancer immunotherapies, either alone or in combination with immune checkpoint inhibitors. New evidence indicates that the expansion of myeloid cell differentiation in pathology is subject to fine-tuning, as its alterations may support either immunosuppression or autoimmunity. This pathological plasticity is supported by evidence indicating that common MDSC-associated targets may be specularly targeted in autoimmunity vs. cancer (12), and there is now hope that understanding autoimmune mechanisms might serve as a lesson for the development of new anticancer therapies. The functional plasticity and therapeutic ductility of these cells (Figure 2) suggest that while MDSC inhibition might succeed as anticancer treatment, their induction is expected to provide therapeutic benefit in autoimmune diseases. FIGURE 2 Figure 2. Schematic role of MDSCs in pathology. Immunological stress induces the expansion of MDSCs that play different roles depending on distinct pathological and microenvironmental contexts. MDSCs are characterized by the strong ability to suppress ...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research

Related Links:

Pfizer has agreed to buy Array Biopharma in a $10.64 billion cash deal.
Source: - Category: Pharmaceuticals Source Type: news
Three times the charm when it comes to Zebra Medical. The Kibbutz Shefayim, Israel-based company has managed to win its third FDA clearance – this time for its artificial intelligence-based technology. The company’s technology is named HealthICH, which is an AI alert for intracranial hemorrhage.Zebra Med's intracranial hemorrhage triage solution can provide early detection of people who may have experienced a brain bleed. The algorithm is comprised of a, tailor-made neural network architecture designed to identify intracranial hemorrhage while tackling several challenges, such as relativ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news
Source: BMJ News - Category: General Medicine Source Type: research
(CNN) — Your social media could reveal a lot more about you than you think. Say, for example, whether you have a medical condition. In a new study, researchers were able to predict 21 types of medical conditions — ranging from pregnancy to skin disorders — by analyzing people’s Facebook profiles. Facebook status updates were “particularly effective at predicting diabetes and mental health conditions including anxiety, depression and psychoses,” the study found. The study will be published June 19 in PLOS One, a peer-reviewed open access scientific journal published since 2006 “Peop...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Offbeat CNN Facebook Source Type: news
The D2d trial showed that vitamin D supplementation does not prevent type 2 diabetes in those at risk. Drs Pittas and Shubrook discuss what else we can learn from this trial.Medscape Diabetes &Endocrinology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news
Abstract The commercial production of high quality natural rubber (NR) solely depends on Hevea brasiliensis Muell. Arg, (Para rubber tree) and accounts for>98% of total production worldwide. NR with its unique properties is an essential commodity for the automobile industry and its synthetic counterparts are in no way substitute to it. The rubber tree genome is very complex and plays an important role in delivering the unique properties of Hevea. But a lack of knowledge on the molecular mechanisms of rubber biosynthesis, disease resistance, etc., in elite clones of rubber still persists. Marker-assisted selecti...
Source: Advances in Genetics - Category: Genetics & Stem Cells Authors: Tags: Adv Genet Source Type: research
CCR Grand Rounds Kimberly Stegmaier, M.D., Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for pediatric cancers. She is the Vice Chair for Pediatric Oncology Research, co-director of the Pediatric Hematologic Malignancy Program and an attending physician providing clinical care in Pediatric Oncology at the Dana-Farber Cancer Institute and Boston Children ’ s Hospital. Dr. Stegmaier is also an Institute Member of the Broad Institute of Harvard and MIT. She has served as a Council...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
DiabetesMine covers an array of new diabetes research presented at the American Diabetes Association's Scientific Sessions in early June 2019.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
ConclusionExperimental validation of network analysis revealed anti-diabetic effects of the plant product SGD, manifested most notably by improved serum profiles and diminished insulin resistance. These experimental results may have clinical implications.Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
Public workshop
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news
More News: Allergy | Allergy & Immunology | Alopecia | Alopecia Areata | Antidoxidants | Arthritis | Aspirin | Autoimmune Disease | Biology | Bladder Cancer | Bone Graft | Brain | Breast Cancer | Breast Carcinoma | Calcium | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Cancer Therapy | Carcinoma | Chemotherapy | Cialis | Clinical Trials | Colon Cancer | Colorectal Cancer | Crohn's Disease | Cytology | Diabetes | Diabetes Type 1 | Disability | Emergency Medicine | Endocrinology | Environmental Health | Epithelial Cancer | Esophagus Cancer | Fortamet | Funding | Gastroenterology | Genetics | Glomeruli | Head and Neck Cancer | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | HNSCC | Immunotherapy | Infectious Diseases | Inflammatory Bowel Disease | Insulin | Italy Health | Kidney Cancer | Kidney Transplant | Kidney Transplantation | Lessons | Liver | Liver Cancer | Liver Transplant | Lung Cancer | Lung Transplant | Lupus | Lymphoma | Melanoma | Men | Metformin | Mitochondria | Mitochondrial Disease | Multiple Sclerosis | Myasthenia Gravis | Myeloma | Nephritis | Neurology | Niacin | Non-Small Cell Lung Cancer | Noonan Syndrome | Nutrition | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Parenteral Nutrition | Pathology | Pharyngeal Cancer | Pregnancy | Pregnancy and Breast Cancer | Primary CNS Lymphoma | Psoriasis | Renal Cell Carcinoma | Rheumatoid Arthritis | Rheumatology | Skin | Skin Cancer | Skin Graft | Spinal Cord Injury | Squamous Cell Carcinoma | Staphylococcus Aureus | Stem Cell Therapy | Stem Cells | Study | Thrombocytopenia | Transplants | Tuberculosis | Ulcerative Colitis | Urology & Nephrology | Viagra | Women | Yervoy